OA-SRESEARCH PLATFORM

Functional imaging you can program.

The first no contact opto-acoustic scanner with an open API.

Open API Raw data access Gel-free & contact-free
Applications

What it’s built to image.

Functional, label-free, and non‑contact: across the studies opto‑acoustics does best.

Opto-acoustic scan of tumour angiogenesis

Tumor angiogenesis

Designed to watch tumors recruit their own blood supply, label-free.

Opto-acoustic perfusion and blood-flow map

Perfusion & flow

Designed to map vascular structure and blood‑flow dynamics in 3-D.

Oxygen-saturation map with a hypoxic core and oxygenated rim

Oxygen saturation

Designed to quantify tissue sO₂ without contrast or dyes.

Tumour vasculature regressing after therapy

Therapy response

Designed to track change over time, non‑invasively, in the same subject.

The problem

Today's opto-acoustic rigs box you in.

If you work with opto-acoustics, you know the compromises: gel everywhere, slow manual sweeps, and a black box that won't hand back the raw data. OA Signal was built the opposite way: open, and hands-off.

Conventional OA systems
  • Gel-coupled probes: coupling artifacts and messy subject handling.
  • Manual raster sweeps: minutes of step-and-shoot per volume.
  • Closed reconstruction: no raw wavefield, fixed scan modes.
  • Contact pressure distorts the very vasculature you're imaging.
The OA Signal platform
  • Gel-free, contact-free: nothing touches the subject — no coupling, simpler animal handling.
  • Single-shot, multi-channel: designed to capture a full 3-D volume, not step-and-shoot.
  • Open API + raw wavefield: your reconstruction, your scan modes.
  • Multi-wavelength functional: hemoglobin and oxygen saturation in 3-D.
Design targets

The research unit, at a glance.

2–4 cm
target penetration depth
~100 µm
target spatial resolution
Multi-λ
near-infrared, functional
Non-contact
interferometric detection
Let’s talk

Put it in your lab.

A multi-channel opto-acoustic scanner with an open API, planned for oncology, vascular, and CRO labs. We’re signing early research partners now.